1. Cuproptosis in cancer: biological implications and therapeutic opportunities
   Liping Li et al, 2024, Cellular & Molecular Biology Letters CrossRef
2. Association between Polymorphism of Genes IL-1A, NFKB1, PAR1, TP53, and UCP2 and Susceptibility to Non-Small Cell Lung Cancer in the Brazilian Amazon
   Esdras E. B. Pereira et al, 2023, Genes CrossRef
3. Synthesis and neuroprotective effects of new genipin derivatives against glutamate-induced oxidative damage
   Liping Luo et al, 2023, Fitoterapia CrossRef
4. UCP2 and pancreatic cancer: conscious uncoupling for therapeutic effect
   Emily G. Caggiano et al, 2024, Cancer and Metastasis Reviews CrossRef
5. CD133 increases oxidative glucose metabolism of HT29 cancer cells by mitochondrial uncoupling and its inhibition enhances reactive oxygen species-inducing therapy
   Jin Hee Lee et al, 2022, Nuclear Medicine Communications CrossRef
6. Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives
   Chenliang Zhang et al, 2024, Journal of Hematology & Oncology CrossRef
7. Role of UCP2 in the Energy Metabolism of the Cancer Cell Line A549
   Jessica Segalés et al, 2023, International Journal of Molecular Sciences CrossRef
8. Copper in cancer: from limiting nutrient to therapeutic target
   Xiaolong Tang et al, 2023, Frontiers in Oncology CrossRef
9. Novel Findings regarding the Bioactivity of the Natural Blue Pigment Genipin in Human Diseases
   Magdalena Bryś et al, 2022, International Journal of Molecular Sciences CrossRef
10. UCP2 as a Cancer Target through Energy Metabolism and Oxidative Stress Control
    Angèle Luby et al, 2022, International Journal of Molecular Sciences CrossRef
11. Emerging role and the signaling pathways of uncoupling protein 2 in kidney diseases
    Song Mao, 2024, Renal Failure CrossRef
12. Cuproptosis in lung cancer: mechanisms and therapeutic potential
    Qixuan Li et al, 2024, Molecular and Cellular Biochemistry CrossRef
13. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
    Peijie Zheng et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
14. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications
    Mojtaba Tarin et al, 2023, Journal of Translational Medicine CrossRef
15. Genipin, an Inhibitor of UCP2 as a Promising New Anticancer Agent: A Review of the Literature
    Young Seok Cho, 2022, International Journal of Molecular Sciences CrossRef
16. Brown adipocytes promote epithelial mesenchymal transition of neuroblastoma cells by inducing PPAR-γ/UCP2 expression
    Zhijuan Ge et al, 2022, Adipocyte CrossRef
17. Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway
    Ke-Xin Sun et al, 2023, World Journal of Diabetes CrossRef
18. UCP2 promotes NSCLC proliferation and glycolysis via the mTOR/HIF‐1α signaling
    Cailu Song et al, 2024, Cancer Medicine CrossRef